AtaiBeckley (ATAI) Receivables - Net (2023 - 2026)

AtaiBeckley (ATAI) recorded quarterly Receivables - Net of $864000.0 in Q1 2026, up 29.54% quarter-over-quarter from $667000.0 in Q4 2025.

AtaiBeckley (ATAI) Receivables - Net (2023 - 2026) Analysis & Trends

AtaiBeckley's Receivables - Net history runs 3 years deep, the most recent figure standing at $864000.0 for Q1 2026.

  • In Q1 2026, Receivables - Net changed N/A year-over-year to $864000.0; the TTM figure through Mar 2026 stood at $864000.0 (changed N/A YoY), while the FY2025 annual figure was $667000.0, up 88.42% from the prior year.
  • Receivables - Net was $864000.0 for Q1 2026 at AtaiBeckley, up from $667000.0 in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $261000.0 in Q4 2024 to a low of $46000.0 in Q1 2025.
  • The 3-year median for Receivables - Net is $65000.0 (2023), against an average of $109250.0.
  • Biggest YoY gain for Receivables - Net was 88.42% in 2025; the steepest drop was 88.42% in 2025.
  • A 3-year view of Receivables - Net shows it stood at $354000.0 in 2024, then soared by 88.42% to $667000.0 in 2025, then gained by 29.54% to $864000.0 in 2026.
  • The last three Receivables - Net figures came in at $864000.0 (Q1 2026), $667000.0 (Q4 2025), and $354000.0 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 AtaiBeckley 1.45 Bn 1.45 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 864,000.00
Mar 31, 2026 864,000.00
Dec 31, 2025 667,000.00
Dec 31, 2025 667,000.00
Sep 30, 2025 46,000.00
Sep 30, 2025 46,000.00
Mar 31, 2025 46,000.00
Mar 31, 2025 46,000.00
Dec 31, 2024 261,000.00
Dec 31, 2024 261,000.00
Dec 31, 2024 354,000.00
Dec 31, 2024 354,000.00
Dec 31, 2023 84,000.00
Dec 31, 2023 84,000.00